Ward Shane — SEC Form 4 filings
SEC reporting owner CIK 1638380. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-07.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-12 to 2026-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 32,096 shares, $2,242,002 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 9,959 shares @ $220.08 ($2,191,747) in Cidara Therapeutics, Inc., filed 2025-12-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) | COO & CLO | 7 | — | 3 legs · 32,096 sh · $2,242,002 | 16 |
Form 4 filings — Ward Shane
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-07 | 4 | Cidara Therapeutics, Inc. (CDTX) | Disposition to issuer (D): 25,083 @ $221.50 · Disposition to issuer (D): 12,500 (derivative) · Disposition to issuer (D): 6,207 (derivative) · Disposition to issuer (D): 12,499 (derivative) · Disposition to issuer (D): 135,540 (derivative) · Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2025-12-12 | 4 | Cidara Therapeutics, Inc. (CDTX) | Tax withholding (F): 15,041 @ $219.60 · Option exercise (M): 3,500 @ $16.65 · Option exercise (M): 6,459 @ $20.20 · Sale (S): 9,959 @ $220.08 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 6,459 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Cidara Therapeutics, Inc. (CDTX) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Cidara Therapeutics, Inc. (CDTX) | Sale (S): 1,664 @ $21.96 | EDGAR |
| 2024-10-02 | 4 | Cidara Therapeutics, Inc. (CDTX) | Grant/award (A): 135,540 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Cidara Therapeutics, Inc. (CDTX) | Grant/award (A): 120,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Cidara Therapeutics, Inc. (CDTX) | Sale (S): 20,473 @ $0.67 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1638380 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →